Keyword: Michel Vounatsos

George Scangos

10. George Scangos

George Scangos left Biogen on an up note, but the company has plenty of challenges ahead. For his final year as CEO, Scangos' total compensation added up to $17.73 million.
ticker screens

Biopharma's Q1 earnings, all in one place

Every quarter, the FiercePharma team analyzes biopharma earnings reports and investor calls, and we're compiling the first quarter's here. Check back daily for updates.